Oslo, Norway, 5 May 2022: Photocure ASA (Photocure, PHO: OSE) will announce the
first quarter 2022 financial results on Wednesday 11 May 2022 at 08:00 CET and
invites investors, analysts and the media to a presentation at Hotel
Continental, Oslo, Norway at 14:00 CET the same day.
The investor presentation will also be streamed live and be hosted by Daniel
Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and
questions can be submitted throughout the event.
The presentation is scheduled to conclude at 14:45 CET.
The quarterly report and presentation will be published at 08:00 CET and will be
publicly available at www.photocure.com. The streaming event is available
through
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20220511_7
For further information, please contact:
Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.